Asker Healthcare Group has acquired 100 percent of the shares in Novus Med Holdings Limited, a leading niche distributor of endoscopic surgical technology and patient positioning systems solutions in the UK. Novus Med has 12 employees and generated revenues of approximately SEK 80 million in the most recent financial year ending June 2025. The acquisition is an add-on acquisition to HSL Group and is expected to contribute positively to the Group's EBITA margin.
|
Published October 2, 2025
Asker Healthcare acquires British Novus Med
Notes
Sofinnova Partners raises EUR 650 million in new fund
Merck acquires Cidara for approximately USD 9,2 billion
Coegin Pharma launches first Follicopeptide product
Ascelia Pharma receives FDA acceptance for Orviglance application
Diamyd Medical passes safety review ahead of Phase III readout
Egetis reports positive results from the ReTRIACt study
Mikael Dolsten withdraws his nomination to Novo's board
NEWSLETTER
Today's news roundup
News roundup Monday, November 17
Upcoming events
MedTech Summit 2026
A new, much-needed MedTech forum in one of Europe's leading life science clusters. As the first event of its kind...
Recommended
Pila Pharma stands out in next-generation obesity pipeline
Novo Nordisk challenges Pfizer in billion-dollar battle for Metsera
New major investment will strengthen Europe's life science sector
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
SwedenBIO wants to give growth power to the industry
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account